by Mybiogate | Oct 26, 2020 | Industry Research
Author: HE Sheng Masitinib and other indications enter clinical research Masitinib mesylate was developed by AB Science. Its clinical indications include amyotrophic lateral sclerosis (ALS), Alzheimer’s (AD), mastocytosis, pancreatic cancer, multiple sclerosis,... by Mybiogate | Oct 23, 2020 | Industry Research
Author: HE Sheng Age-related macular degeneration (AMD) is a serious and irreversible cause of visual impairment. It is also a leading cause of blindness among the elderly. As populations in China and around the world age, it is estimated that the number of... by Mybiogate | Oct 22, 2020 | Industry Research
Author: HE Sheng Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s disease. It is caused by low levels of dopamine in the patient’s brain. As the disease progresses, the production of dopamine... by Mybiogate | Oct 21, 2020 | Industry Research
Author:MJ Yuan Editor:Ginger The history of human existence and development has also been a history of struggle against viruses. With recent outbreaks of SARS in 2003, MERS in 2012, or the current novel coronavirus in 2020, again and again there is an... by Mybiogate | Oct 20, 2020 | Chinese company profile
Tasly Holding Group 2019 Revenue: US$ 19.0 Billion Number of Employees: 10,000 Founded: 1994 Overview Incorporated in 1994, Tasly Holding Group has since developed into an international and high-tech cooperation, engaging in the pan-health industry with the biological...